Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,371,597 papers from all fields of science
Search
Sign In
Create Free Account
CD248 gene
Known as:
ENDOSIALIN
, CD248
, CD248 molecule
Expand
This gene may play a role in angiogenesis.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Angiogenic Process
CD248 protein, human
Narrower (1)
CD248 wt Allele
Broader (1)
Genes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy
Xiaopeng Yuan
,
Mingjuan Yang
,
+15 authors
Aizhi Zhao
Cancer Immunology and Immunotherapy
2016
Corpus ID: 5250695
Tumor endothelial marker 1 (TEM1) has been identified as a novel surface marker upregulated on the blood vessels and stroma in…
Expand
2016
2016
Novel antibody probes for the characterization of endosialin/TEM-1
D. O'Shannessy
,
Michael F. Smith
,
+11 authors
N. Nicolaides
OncoTarget
2016
Corpus ID: 5491277
Endosialin (Tumor Endothelial Marker-1 (TEM-1), CD248) is primarily expressed on pericytes of tumor-associated microvasculature…
Expand
2015
2015
CD248/Endosialin: A Novel Pericyte Target in Renal Fibrosis
Monica Chang-Panesso
,
B. Humphreys
Nephron
2015
Corpus ID: 1207711
pericyte to myofibroblast transition and CKD. CD248 was first identified as a tumor vascular endothelial antigen in the early…
Expand
2013
2013
Facile immunotargeting of nanoparticles against tumor antigens using site-specific biotinylated antibody fragments.
Andrew M Prantner
,
Calvin Nguyen
,
N. Scholler
Journal of Biomedical Nanotechnology
2013
Corpus ID: 25070131
Nanotechnology is actively being developed for preclinical and clinical oncology applications. Nanoparticle-based immunotargeting…
Expand
2012
2012
Cdc5-Dependent Asymmetric Localization of Bfa1 Fine-Tunes Timely Mitotic Exit
Junwon Kim
,
Guangming Luo
,
Y. Bahk
,
K. Song
PLoS Genetics
2012
Corpus ID: 724378
In budding yeast, the major regulator of the mitotic exit network (MEN) is Tem1, a GTPase, which is inhibited by the GTPase…
Expand
Review
2011
Review
2011
Endosialin: a novel malignant cell therapeutic target for neuroblastoma.
C. Rouleau
,
Robert Smale
,
+17 authors
B. Teicher
International Journal of Oncology
2011
Corpus ID: 207553367
Endosialin emerged recently as a potential therapeutic target for sarcoma. Since some sarcoma subtypes, such as Ewing's sarcoma…
Expand
2010
2010
No PDGF receptor signal in pericytes without endosialin?
J. Demoulin
Cancer Biology & Therapy
2010
Corpus ID: 26274008
Commentary to: Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling Brian Tomkowicz, Kathy…
Expand
2006
2006
Modulation of effector affinity by hinge region mutations also modulates switching activity in an engineered allosteric TEM1 beta-lactamase switch.
J. Kim
,
M. Ostermeier
Archives of Biochemistry and Biophysics
2006
Corpus ID: 27344362
Highly Cited
1998
Highly Cited
1998
Morphogenesis beyond Cytokinetic Arrest in Saccharomyces cerevisiae
J. Jiménez
,
V. J. Cid
,
+4 authors
Miguel Sánchez
Journal of Cell Biology
1998
Corpus ID: 16370237
The budding yeast lyt1 mutation causes cell lysis. We report here that lyt1 is an allele of cdc15, a gene which encodes a protein…
Expand
1996
1996
New marker for blood vessels in human ovarian and endometrial cancers.
M. Samoszuk
,
F. Lin
,
P. Rim
,
G. Strathearn
Clinical Cancer Research
1996
Corpus ID: 2074376
Angiogenesis plays a critical role in tumor biology and may someday be a target for novel therapeutic interventions. To date…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE